WHO ICTRP trial
Prospective on evaluation of use of, â??AyurCoro3â?? as an add on medication…
CTRI/2020/10/028333 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2020/10/028333 |
|---|---|
| Public title | Prospective on evaluation of use of , â??AyurCoro3â?? as an add on medication for the treatment purpose in COVID-19 patients |
| Scientific title | Prospective , multi center ,single blind , randomized controlled study on evaluation of use of , â??AyurCoro3â?? as an adjuvant for the treatment purpose in mild to moderate COVID-19 patients at tertiary care center. - AyurCoro3 |
| Primary sponsor | Shri Sarveshwar Seva Sahkari Samstha |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3/ Phase 4 |
| Countries | India |
| Conditions | Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere |
| Interventions | Intervention1: AyurCov3: 10 Ml three times a day for 3 days . One day medication Control Intervention1: Standard of care: As per routine clinical care |
| Registration date | Sep 10, 2020 |
| Target size | 500 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: